Among them, human Y1 receptor (hY1R),88,89 gastrin-releasing peptide receptor (GRPR),90 and ghrelin receptor (GhrR)91,92 have become viable targets for BNCT by virtue of their high expression on the surface of cancer cells and their ability to internalize the bound ligands. This evidence concerns the gene GRPR and cancer.